Pylarify
Ended Awarded Last action
- Contract number
- 36C25024F0429
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,623,924
Award facts
- Contract value 100% obligated
- $1,623,924.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awards Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc., $1,623,924 to provide PYLARIFY under the Pharmaceuticals and Drugs federal supply schedule. PYLARIFY is a radioactive diagnostic agent used in positron emission tomography scans to detect prostate cancer. This firm fixed price order has a period of performance through March 2025. Progenics Pharmaceuticals holds multiple federal vehicles to supply pharmaceuticals and radiopharmaceuticals for cancer detection to federal agencies such as the Department of Veterans Affairs, Defense Health Agency, and National Institutes of Health Clinical Center.
Quick answers
Who was awarded contract 36C25024F0429?
36C25024F0429 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on March 15, 2024.
How much is contract 36C25024F0429 worth?
The government has obligated $1,623,924 on 36C25024F0429.
Is contract 36C25024F0429 an order under another contract?
Yes. 36C25024F0429 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25024F0429 competed?
The extent of competition for 36C25024F0429 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award